Hot Pursuit
Prev Next
As on Aug 20, 2019 12:00 AM Your results on : Hot Pursuit    
SeQuent Scientific rises on receiving EIR from USFDA for Bengaluru lab
20-Aug-2019 (15:38)

SeQuent Scientific announced during trading hours today, 20 August 2019, that its wholly owned subsidiary, SeQuent Research, has received Establishment Inspection Report (EIR) from USFDA for its GLP compliant, analytical services laboratory at Bengaluru.

The Bengaluru laboratory was set up in 2017 to cater to the growing analytical requirements of large pharmaceutical and FMCG majors in the region. The facility is equipped with best-in-class infrastructure, strong team of trained analytical scientists and LIMS-enabled Quality Management System. SRL also has another US FDA approved analytical laboratory at Mangaluru, which has been providing services since 2008. The Mangaluru laboratory was successfully inspected by the US FDA in December 2018.

Meanwhile, S&P BSE Sensex was down 86.95 points or 0.23% at 37,315.54.

On BSE, 37,000 shares were traded in SeQuent Scientific counter, compared to a 2-week average of 21,000 shares. The stock hit an intraday high of Rs 72.15 and an intraday low of Rs 69.05.

It hit a 52-week high of Rs 89 on 22 January 2019 and a 52-week low of Rs 42.45 on 9 October 2018.

Shares of SeQuent Scientific gained 5.52% in two trading sessions to its current market price of Rs 71.65, from a recent closing low of Rs 67.90 on Friday, 16 August 2019.

SeQuent Scientific's consolidated net profit jumped 249.4% to Rs 11.46 crore on 18.2% surge in net sales to Rs 278.02 crore in Q1 June 2019 compared with Q1 June 2018.

SeQuent Scientific is a pharmaceutical company. Its segments include pharmaceuticals, speciality chemicals and analytical services. It focuses on products for livestock, poultry and companion animals. It offers laboratory and technical support services also.

NMDC tanks on buzz Karanataka cancels Donimalai lease
20-Aug-2019 (15:20)
CG Power & Industrial Solutions Ltd leads losers in 'A' group
20-Aug-2019 (15:01)
Yes Bank slumps over 10% in two sessions
20-Aug-2019 (14:49)
Superhouse Ltd leads losers in 'B' group
20-Aug-2019 (14:46)
Volumes spurt at Varroc Engineering Ltd counter
20-Aug-2019 (14:31)
Dr Reddy's Labs firms up after launching Vigabatrin powder in US
20-Aug-2019 (14:28)
Eros International Media Ltd spurts 4.82%, gains for five straight sessions
20-Aug-2019 (13:00)
Goldiam Intl surges after winning export orders
20-Aug-2019 (12:38)
CG Power slumps after uncovering financial irregularities
20-Aug-2019 (12:31)
Industrial Investment Trust Ltd leads gainers in 'B' group
20-Aug-2019 (12:15)
Venkys (India) Ltd leads gainers in 'A' group
20-Aug-2019 (12:00)
IT shares in demand on weak rupee
20-Aug-2019 (11:52)
MRPL slips after minor landslide affects operations
20-Aug-2019 (11:32)
Volumes soar at Bajaj Electricals Ltd counter
20-Aug-2019 (11:00)
Sterling & Wilson Solar slips on debut
20-Aug-2019 (10:57)
Mahanagar Gas spurts on buzz of Shell's exit
20-Aug-2019 (10:33)
Steel Authority of India Ltd Falls 1.53%
20-Aug-2019 (09:45)
HFCL sizzles after new order win
20-Aug-2019 (09:26)
AXISCADES Engineering Technologies Ltd Spurts 5.02%, S&P BSE IT Sector index Gains 1.01%
20-Aug-2019 (09:30)
Connect with us :   
About us
Our Services
Core Values
Investor Relations
Product & Services
Institutional Broking
Clearing Services
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
NSDL e-KYC Signer Application
Back Office
Back Office
KYC/KDC Status
Mutual Fund
RMS Policy
Download Forms
Useful Links
Exchange Holidays
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to / (For Trading) (For DP) (For PMS) (For Commodities)
Equity SEBI Registration No INZ000177137. Exchange Registration Nos NSE : TM No. - 06637, Clearing No.- M50302 | BSE : Clearing No.- 3179 | MSEI : TM Code-1004, Clearing Member Code- 4 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No. INH100001187 | SEBI PMS Registration No. INP00000236
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions